103 related articles for article (PubMed ID: 7520333)
21. p53 mutations in esophageal tumors from a high incidence area of China in relation to patient diet and smoking history.
Bennett WP; von Brevern MC; Zhu SM; Bartsch H; Muehlbauer KR; Hollstein MC
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):963-6. PubMed ID: 9367071
[TBL] [Abstract][Full Text] [Related]
22. Expression of p53 and p21WAF1/CIP1 proteins in gastric and esophageal cancers: comparison with mutations of the p53 gene.
Seta T; Imazeki F; Yokosuka O; Saisho H; Suzuki T; Koide Y; Isono K
Dig Dis Sci; 1998 Feb; 43(2):279-89. PubMed ID: 9512119
[TBL] [Abstract][Full Text] [Related]
23. [The significance of p53 gene mutations and expressions in human colorectal tumors].
Qian H; Yu B; Zhou X
Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):332-5. PubMed ID: 8697968
[TBL] [Abstract][Full Text] [Related]
24. Mutation in the p53 tumor suppressor gene in rat esophageal papillomas induced by N-nitrosomethylbenzylamine.
Wang D; Weghorst CM; Calvert RJ; Stoner GD
Carcinogenesis; 1996 Apr; 17(4):625-30. PubMed ID: 8625469
[TBL] [Abstract][Full Text] [Related]
25. Clinical implications of p53 gene mutation in the progression of Barrett's epithelium to invasive esophageal cancer.
Casson AG; Manolopoulos B; Troster M; Kerkvliet N; O'Malley F; Inculet R; Finley R; Roth JA
Am J Surg; 1994 Jan; 167(1):52-7. PubMed ID: 8311140
[TBL] [Abstract][Full Text] [Related]
26. Role of p53 gene mutations in human esophageal carcinogenesis: results from immunohistochemical and mutation analyses of carcinomas and nearby non-cancerous lesions.
Shi ST; Yang GY; Wang LD; Xue Z; Feng B; Ding W; Xing EP; Yang CS
Carcinogenesis; 1999 Apr; 20(4):591-7. PubMed ID: 10223186
[TBL] [Abstract][Full Text] [Related]
27. Benzo[a]pyrene-induced mutagenesis of p53 hot-spot codons 248 and 249 in human hepatocytes.
Cherpillod P; Amstad PA
Mol Carcinog; 1995 May; 13(1):15-20. PubMed ID: 7766306
[TBL] [Abstract][Full Text] [Related]
28. Mutagenesis of the H-ras protooncogene and the p53 tumor suppressor gene.
Cerutti P; Hussain P; Pourzand C; Aguilar F
Cancer Res; 1994 Apr; 54(7 Suppl):1934s-1938s. PubMed ID: 7907948
[TBL] [Abstract][Full Text] [Related]
29. Using biopsy materials to detect mutations in gastrointestinal tumors.
Hosoi H; Hirosawa S; Yamamoto K; Ohkusa T; Aoki N
J Clin Gastroenterol; 1995 Jun; 20(4):272-6. PubMed ID: 7665812
[TBL] [Abstract][Full Text] [Related]
30. P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus.
Schneider PM; Stoeltzing O; Roth JA; Hoelscher AH; Wegerer S; Mizumoto S; Becker K; Dittler HJ; Fink U; Siewert JR
Clin Cancer Res; 2000 Aug; 6(8):3153-8. PubMed ID: 10955797
[TBL] [Abstract][Full Text] [Related]
31. Molecular screening of pituitary adenomas for gene mutations and rearrangements.
Herman V; Drazin NZ; Gonsky R; Melmed S
J Clin Endocrinol Metab; 1993 Jul; 77(1):50-5. PubMed ID: 8100831
[TBL] [Abstract][Full Text] [Related]
32. p53 mutations in flat- and polypoid-type colorectal tumors detected by temperature-gradient gel electrophoresis.
Yamamura-Idei Y; Satonaka K; Fujimori T; Maeda S; Chiba T
Dig Dis Sci; 1994 Sep; 39(9):2043-8. PubMed ID: 8082516
[TBL] [Abstract][Full Text] [Related]
33. p53 mutations in all stages of thyroid carcinomas.
Zou M; Shi Y; Farid NR
J Clin Endocrinol Metab; 1993 Oct; 77(4):1054-8. PubMed ID: 8408453
[TBL] [Abstract][Full Text] [Related]
34. Direct sequencing from touch preparations of human carcinomas: analysis of p53 mutations in breast carcinomas.
Kovach JS; McGovern RM; Cassady JD; Swanson SK; Wold LE; Vogelstein B; Sommer SS
J Natl Cancer Inst; 1991 Jul; 83(14):1004-9. PubMed ID: 1712853
[TBL] [Abstract][Full Text] [Related]
35. p53 gene mutations in pituitary adenomas: rare events.
Levy A; Hall L; Yeudall WA; Lightman SL
Clin Endocrinol (Oxf); 1994 Dec; 41(6):809-14. PubMed ID: 7889618
[TBL] [Abstract][Full Text] [Related]
36. Sensitive detection of p53 gene mutations in esophageal endoscopic biopsy specimens by cell sorting combined with polymerase chain reaction single-strand conformation polymorphism analysis.
Maesawa C; Tamura G; Suzuki Y; Ishida K; Saito K; Satodate R
Jpn J Cancer Res; 1992 Dec; 83(12):1253-6. PubMed ID: 1483940
[TBL] [Abstract][Full Text] [Related]
37. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM
Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216
[TBL] [Abstract][Full Text] [Related]
38. Frequent p53 gene mutations in serrated adenomas of the colorectum.
Hiyama T; Yokozaki H; Shimamoto F; Haruma K; Yasui W; Kajiyama G; Tahara E
J Pathol; 1998 Oct; 186(2):131-9. PubMed ID: 9924427
[TBL] [Abstract][Full Text] [Related]
39. Molecular analysis of p53 tumor-suppressor gene and microsatellites in preneoplastic and neoplastic lesions of the colon and esophagus.
Copelli SB; Mazzeo C; Gimenez A; Casco C; Meiss R; Rubio H; Speroni A; Vanzulli S
Oncol Rep; 2001; 8(4):923-9. PubMed ID: 11410811
[TBL] [Abstract][Full Text] [Related]
40. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]